Uveodermatologic Syndrome (VKH) in Dogs: When Skin and Eyes Are Both Affected

Based on peer reviewed veterinary research · For educational purposes only · Updated October 2026 · 9 min read

What Is Uveodermatologic Syndrome in Dogs?

Uveodermatologic syndrome is a rare autoimmune disease in which a dog's immune system mistakenly attacks melanocytes, the cells that produce pigment in both the skin and the eyes, causing simultaneous skin depigmentation and severe eye inflammation. It is named for its resemblance to Vogt-Koyanagi-Harada (VKH) disease in humans, so veterinarians often call it VKH-like syndrome.

The syndrome affects two organ systems at once. In the eyes, the immune attack triggers uveitis (inflammation of the middle layer of the eye), which is painful and can rapidly threaten vision. In the skin, the loss of melanocytes produces striking depigmentation, turning a black nose pink or white and causing whitening of the fur and skin around the face.

This is an uncommon condition, but it is heavily breed-associated. The Akita is by far the most frequently reported breed, and other Arctic or Nordic breeds including the Samoyed, Siberian Husky, Alaskan Malamute, and Chow Chow are also predisposed. Because the eye disease can cause irreversible blindness, VKH-like syndrome is considered an ophthalmic emergency whenever it is suspected.

What Causes Uveodermatologic Syndrome?

Uveodermatologic syndrome is caused by a T-cell mediated autoimmune reaction directed against melanin and the melanocytes that produce it. The immune system treats these pigment cells as foreign, mounting a sustained attack that destroys them in the skin, the hair follicles, and the pigmented tissues of the eye (the uveal tract).

The reason the immune system turns against melanocytes is not fully understood, but a genetic predisposition is strongly suspected, given the concentration of cases in Akitas and related breeds. Researchers have investigated links to specific canine immune-system genes (dog leukocyte antigen, or DLA, haplotypes) that may make certain dogs more likely to develop the disease.

Because melanocytes are present in the skin, eyes, inner ear, and central nervous system, the same disease process in people can affect hearing and neurological function. In dogs, the skin and eyes are the primary targets, and there is no evidence that VKH-like syndrome is contagious or caused by diet, infection, or environmental exposure. It is an internal immune malfunction, not something an owner could have prevented.

How Do Veterinarians Diagnose This Syndrome?

Veterinarians diagnose uveodermatologic syndrome using the combination of characteristic clinical signs, a complete eye examination, and a skin biopsy. The pairing of skin depigmentation with uveitis in a predisposed breed such as the Akita is highly suggestive on its own.

A thorough ophthalmic examination is essential, because the eye disease is often more advanced than it appears. An ophthalmologist checks for uveitis, elevated eye pressure (secondary glaucoma), and retinal detachment, any of which can threaten vision. Skin biopsy of depigmented lesions confirms the diagnosis by revealing a specific pattern of inflammation with pigment-laden immune cells (a lichenoid interface dermatitis with melanophages) at the junction between the epidermis and dermis.

Owners who notice a nose changing color or new whitening around the eyes can compare early skin changes using the Dog Skin Condition Checker, but any suspicion of this syndrome warrants urgent veterinary and ophthalmology evaluation. Because depigmentation can also occur with other conditions such as discoid lupus, the biopsy helps distinguish VKH-like syndrome from its mimics.

Signs and Symptoms to Watch For

The earliest sign owners usually notice is the nose losing its black color and turning pink or mottled, but the eye disease is what makes this syndrome dangerous. Skin and eye signs may not appear at the same time, and in many dogs the depigmentation is spotted first while uveitis is already developing silently.

The table below separates the two organ systems affected:

Treatment Options for Uveodermatologic Syndrome

Treatment centers on aggressive, early immunosuppression to stop the immune attack and preserve vision. Dogs are typically started on high-dose oral corticosteroids such as prednisone at 1 to 2 mg/kg twice daily, combined with topical anti-inflammatory eye medications applied by a veterinary ophthalmologist. Steroid-sparing drugs such as azathioprine, ciclosporin, or mycophenolate are added for long-term control so steroid doses can be lowered.

Because the depigmented skin on the nose and around the eyes loses its pigment barrier, it becomes inflamed, tender, and prone to sunburn and secondary irritation. Soothing that fragile skin supports comfort while systemic drugs address the underlying disease. Chlorhexidine Spray contains pramoxine hydrochloride, a topical anesthetic that quiets itch and irritation, along with colloidal oatmeal that helps calm inflamed, sensitive skin, making it a gentle comfort measure for depigmented areas, not a treatment for the syndrome itself.

Strict sun avoidance and dog-safe sunscreen on the nose are important once pigment is lost. For related autoimmune skin conditions, see our guides on Systemic Lupus in Dogs and Bullous Pemphigoid in Dogs, and review the dog skin allergies resource for general skin-soothing guidance. The eye component must always be managed by a veterinary ophthalmologist.

Prevention and Long-Term Management

Uveodermatologic syndrome cannot be prevented, but the difference between preserved and lost vision often comes down to how quickly treatment starts and how consistently it continues. This is a lifelong disease, and stopping medication frequently triggers a relapse that can be worse than the first episode.

Long-term care requires regular rechecks with both a dermatologist and an ophthalmologist, plus periodic bloodwork every 3 to 6 months to monitor for side effects of immunosuppressive drugs. Eye pressure should be checked routinely, because secondary glaucoma is a common and painful complication that can develop even when the disease seems controlled.

At home, owners should protect depigmented skin from sun exposure, watch closely for any change in the eyes, and never abruptly discontinue medication. Prospective owners of predisposed breeds such as Akitas should be aware of the condition, since responsible breeding away from affected lines is the only population-level way to reduce its incidence. With diligent lifelong management, many dogs keep functional vision and a good quality of life.

Frequently Asked Questions

What breeds get uveodermatologic syndrome in dogs?

The Akita is by far the most commonly affected breed. Other predisposed breeds include the Samoyed, Siberian Husky, Alaskan Malamute, Chow Chow, and other Arctic or Nordic breeds, which points to a genetic basis for the disease.

Can uveodermatologic syndrome cause blindness in dogs?

Yes. The uveitis (eye inflammation) associated with this syndrome can rapidly cause secondary glaucoma, retinal detachment, and permanent blindness, sometimes within days. Early aggressive immunosuppressive treatment offers the best chance of preserving vision.

Why is my dog's nose turning pink?

A black nose turning pink or mottled can have several causes, but when it occurs with eye inflammation in a predisposed breed like the Akita, uveodermatologic syndrome is a leading concern. A skin biopsy and eye exam are needed to confirm the diagnosis, so prompt veterinary evaluation is important.

Is uveodermatologic syndrome curable in dogs?

It is not curable, but it is manageable with lifelong immunosuppressive therapy. Most dogs need high-dose corticosteroids initially, tapered to a maintenance dose alongside steroid-sparing drugs. Stopping treatment usually triggers a relapse, so ongoing care is essential.

Sources

1. Angles JM, Famula TR, Pedersen NC. Uveodermatologic (VKH-like) syndrome in American Akita dogs. Journal of the American Veterinary Medical Association. 2005;227(11):1751-1761.
2. Miller WH, Griffin CE, Campbell KL. Muller and Kirk's Small Animal Dermatology. 7th ed. Elsevier. 2013;450-495.
3. Herrera HD, Duchene AG. Uveodermatological syndrome (VKH-like) in dogs. Journal of Small Animal Practice. 1998;39(9):422-425.
4. Zarfoss MK, Dubielzig RR. Canine uveodermatologic syndrome: clinical and histopathologic findings. Veterinary Ophthalmology. 2010;13(5):297-306.

Related Reading

• Systemic Lupus in Dogs: How It Affects Skin, Joints, and Organs
• Bullous Pemphigoid in Dogs: Causes, Diagnosis, and Treatment
• Age-Related Immune Decline and Recurrent Skin Infections in Senior Dogs

E. Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.

Research basis: All Vetified content references peer reviewed research published in journals including Veterinary Dermatology, JAVMA, and Journal of Small Animal Practice.